AVBP
AVBP
US04272N1028
ArriVent BioPharma, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue -- --
--
Cost of Revenue -- --
--
Gross Profit -- --
--
177.534.000 94.308.000
88.2%
Operating Income -177.534.000 -94.308.000
88.2%
Pretax Income -166.308.000 -80.488.000
106.6%
Net Income Common Stockholders -166.308.000 -80.488.000
106.6%
-- --
--
-- --
--
ende